CNS Curative Technologies LLC

The mission of CNS Curative Technologies LLC is to develop ground breaking, disease-modifying intranasal compounds that can reverse neurodegeneration, protein aggregation in the brain, and cognitive decline in patients afflicted by Parkinson's and Alzheimer's disease. Using cutting-edge drug screening and molecular biology approaches, our research and development team has identified lead compounds that significantly enhance brain-protective signaling molecules in both cell culture and animal models. We are currently working to refine an innovative intranasal formulation that can be employed to treat Parkinson's and Alzheimer's patients.